Samsung Biologics (KRX:207940) will wholly acquire Switzerland-based PolyPeptide Group for about 2.71 trillion won to boost the competitiveness of its peptide contract development and manufacturing organization (CDMO) business, according to a Monday filing with the Korean Exchange.
The company will purchase 33.02 million shares, which is the entire issued share capital of PolyPeptide.
Shares of Samsung Biologics fell nearly 2% in recent trade.
Planetree International Development (HKG:0613) expects an attributable profit of HK$600 million for the six months ended June 30, up 555% from HK$108 million a year prior.The financial services company attributed the forecast to a net fair value gain on financial assets, a higher revenue, and an improved contribution from the share of results of associates.
Chinese AI startup Moonshot AI launched its Kimi K3 model recently, causing AI and semiconductor stocks to decline in the U.S. on Friday, Bloomberg reported the same day.Moonshot reportedly claims the model is at par with OpenAI and Anthropic PBC's most powerful offerings.The announcement of the launch coincided with President Xi Jinping's attendance of China's top AI summit, underscoring the country's focus on leading the AI sector, Bloomberg said.Kimi K3, a 2.8T-parameter model with a 1-million-token context window, is the world's first open 3T-class model designed for frontier intelligence across long-horizon coding, knowledge work, and reasoning, according to the company.(Market Chatter news is derived from conversations with market professionals globally. This information is believed to be from reliable sources but may include rumor and speculation. Accuracy is not guaranteed.)
China Everbright Environment (HKG:0257) Chief Executive Officer Luan Zusheng resigned due to age-related reasons, effective Friday, according to a same-day Hong Kong bourse filing.Chairman Wang Silian has assumed the role of Acting CEO, the environmental services provider said.